Percutaneous transluminal stenting versus directional atherectomy for lower limb artery TASC Ⅱ Class A and B superficial femoral artery lesions
10.3760/cma.j.issn.1007-631X.2020.01.012
- VernacularTitle:支架置入与斑块旋切治疗TASCⅡA、B型股浅动脉病变的疗效观察
- Author:
Jinkai LI
1
;
Jingbo KONG
;
Mei HUANG
;
Jianpeng CAO
;
Shugang YIN
;
Bing DAI
;
Nan ZHANG
;
Song ZHANG
;
Wenlu ZHAO
Author Information
1. 天津市天津医院血管外科 300211
- Keywords:
Peripheral artery disease;
Claudication;
Superficial femoral artery;
Stents;
Directional atherectomy
- From:
Chinese Journal of General Surgery
2020;35(1):42-45
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the effect and safety of stenting versus directional atherectomy (DA) in the treatment of TASCⅡ A and B superficial femoral artery lesions.Methods 100 patients with TASC Ⅱ A and B lesions were divided into percutaneous transluminal stenting(PTS) group (n =50) and DA group (n =50).Patients were compared in terms of technical success rate,treatment success rate,first operation cost,postoperative ankle brachial index (ABI),limb salvage rate,survival,and patency.Results The technical success rate in both PTS and DA group was 100％.The treatment success rate was 98％ vs.86％,P＞0.05.Postoperative ABI:0.82 ±0.19 vs.0.80 ±0.27,P＞0.05.First operation cost:(34 820 ± 1 051) yuan vs.(45 635 ± 1 358) yuan,P ＜0.001;All patients were followed-up for up to 2-year,the cumulative patency rate was 81.6％ vs.72.9％ (P＞0.05).Limb salvage rate was 97.9％ vs.93.8 ％,P ＞ 0.05.Conclusion There were no significant differences in the effect and safety of PTS versus DA in the treatment of TASCⅡ A and B superficial femoral artery lesions.
